Changes in Doppler-Derived Kidney Venous Flow and Adverse Cardiorenal Outcomes in Patients With Heart Failure

Faeq Husain-Syed1,2, Narayana Sarma V Singam3,4, Jason K Viehman5

  • 1Department of Internal Medicine II University Hospital Giessen and Marburg, Justus-Liebig-University Giessen Giessen Germany.

Insights

Changes in kidney venous flow, measured by kidney venous stasis index (KVSI) and intrakidney venous-flow (IKVF) patterns, predict adverse cardiorenal outcomes in heart failure (HF) patients. Serial assessments enhance risk stratification for better clinical decisions.

Area of Science:

  • Cardiology
  • Nephrology
  • Medical Imaging

Background:

  • Heart failure (HF) management is challenged by cardiorenal complications.
  • The role of Doppler-derived kidney venous flow in HF prognosis is understudied.
  • Kidney venous stasis index (KVSI) and intrakidney venous-flow (IKVF) patterns are novel metrics.

Purpose of the Study:

  • To investigate the association between KVSI and IKVF patterns and adverse cardiorenal outcomes in HF patients.
  • To determine if changes in these venous flow parameters over time predict outcomes.
  • To explore the utility of serial kidney venous flow assessment in HF risk stratification.

Main Methods:

  • Observational cohort study of 216 HF inpatients with diuretic resistance and abnormal kidney function.
  • Spectral kidney assessments (Doppler 1 and Doppler 2) to measure KVSI and IKVF patterns.
  • Cox proportional hazard regression models to analyze associations with cardiorenal events up to 18 months.

Main Results:

  • Both baseline KVSI and IKVF pattern severity were significantly associated with worsening HF or death.
  • Increases in KVSI and IKVF pattern severity from baseline to follow-up independently predicted increased risk of adverse events.
  • Similar associations were observed for kidney-specific outcomes.

Conclusions:

  • Baseline kidney venous flow parameters (KVSI, IKVF) are significant predictors of cardiorenal events in HF.
  • Serial assessment of kidney venous flow provides valuable prognostic information.
  • Integrating serial kidney venous flow assessments into cardiorenal risk stratification can aid clinical decision-making for HF patients.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
420
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
25
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
35